Intellectual Property

Capretto has strengthen their position by in-licensing and by establishing internal innovation. These patents provide global protection for all uses of monocaprin and monolaurin as medical devices for a wide range of bacterial, viral and fungal infections. Our technology protects the use of monoglycerides in formulations to manage these infections as well as to improve the antimicrobial efficacy of these lipids. 

Seeking collaboration 

We are actively seeking collaborators to bring our pipeline across the globe.